← FDA DRUG APPROVALS

FDA NDA · NDA020784

NASACORT HFA

Sponsor: SANOFI AVENTIS US

APPLICATION
NDA020784
TYPE
NDA
ORIGINAL APPROVAL
2004-04-07
LATEST ACTION
2004-04-07
ROUTE
NASAL
DOSAGE FORM
SPRAY, METERED
MARKETING STATUS
Discontinued

Products

NASACORT HFADiscontinued
TRIAMCINOLONE ACETONIDE 0.055MG/SPRAY · SPRAY, METERED · NASAL

Approval history

2004-04-07Type 3 - New Dosage Form · Original · standardReviewAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →